Radioimmunodetection and radioimmunotherapy of breast cancer.
Riva
P
P
Nuclear Medicine Division, M. Bufalini Hospital Cesena, Italy.
Franceschi
G
G
Gentile
R
R
Riva
N
N
Casi
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D016719:Radioimmunodetection / Q000009:adverse effects / Q000379:methods; D016499:Radioimmunotherapy / Q000009:adverse effects / Q000379:methods; D019275:Radiopharmaceuticals; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; C091202:B72.3 antibody; C107071:FO23C5 monoclonal antibody; D019275:Radiopharmaceuticals